WebDisclosure WebDisclosure
Basculer en Français
9473 Companies
185423 Keywords
117773 Articles
99292 Press releases
Headlines Articles Press releases
  1. Home
  2. Press releases
  3. MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
WebDisclosure
Basculer en Français
Headlines Articles Press releases
REGULATED PRESS RELEASE

published on 11/20/2024 at 17:45 from MEDESIS PHARMA (EPA:ALMDP)

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM

image

image

image

image

image

image

image

image

image

image

image

image

image

image

image

image

image

image

image

image

imageimage

image

image

image

image

image
image

image

image

See all MEDESIS PHARMA news

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy